Development of A MERS-CoV Replicon Cell Line for Antiviral Screening

• Jing Chen ^1,2 , 
• Bing-Jie Hu ^1,2 , 
• Kai Zhao ^1,2 , 
• Yun Luo ^1,2 , 
• Hao-Feng Lin ^1,2 , 
• Zheng-Li Shi ^{1 ,,}

cstr: 32224.14.s12250-020-00341-z

• 1.

  CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China

• 2.

  University of Chinese Academy of Sciences, Beijing, 100049, China

• Corresponding author: Zheng-Li Shi, zlshi@wh.iov.cn, ORCID: http://orcid.org/0000-0001-8089-163X